Skip to main content
. 2020 May 22;12(Suppl 1):85–92. doi: 10.1007/s13193-020-01096-5

Table 2.

Expression of E-cadherin, VEGF, MMPs (MMP-1, MMP-2, MMP-9) in gastric cancer

S. no. Genes Gastric cancer
n (%)
Normal control
n (%)
p value
1. VEGF

Upregulated

Downregulated

No change

7 (9.6%)

0

66 (90.4%)

3 (11.1%)

0

24 (88.9%)

> 0.05
2. E-cadherin

Upregulated

Downregulated

No change

10 (13.7%)

35 (47.9%)

28 (38.4%)

4 (14.8%)

22 (81.5%)

1 (3.7%)

< 0.01*
3. MMP-1

Upregulated

Downregulated

No change

10 (13.7%)

0

63 (86.3%)

3 (11.1%)

0

24 (88.9%)

> 0.05
4. MMP-2

Upregulated

Downregulated

No change

21 (28.8%)

0

52 (71.2%)

1 (3.7%)

0

26 (96.3%)

< 0.01*
5. MMP-9

Upregulated

Downregulated

No change

8 (11%)

0

65 (89%)

3 (11.1%)

0

24 (88.9%)

> 0.05